Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression
Clinical trial NCT07644767 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07644767
- Sponsor
- Neurocentrx Pharma Pty Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2028-01-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.